Related Experiment Videos
New frontiers for rare pulmonary diseases
Carlo Agostini1, Sergio Harari
1Padua University School of Medicine, Department of Clinical and Experimental Medicine, Clinical Immunology, Padua, Italy. carlo.agostini@unipd.it
Summary
The First International Conference on Rare Pulmonary Diseases and Orphan Drugs in Respiratory Medicine convened leading experts to discuss advances in interstitial lung diseases. The meeting highlighted recent progress in the pathogenesis, diagnosis, and therapy of rare lung disorders.
Area of Science:
- Pulmonary Medicine
- Rare Diseases
- Interstitial Lung Diseases
Background:
- The First International Conference on Rare Pulmonary Diseases and Orphan Drugs in Respiratory Medicine was held in Milan in February 2005.
- The conference focused on interstitial lung diseases, bringing together global authorities in the field.
Purpose of the Study:
- To assess current knowledge on the pathogenesis, diagnosis, and therapy of rare lung disorders.
- To facilitate discussion among over 200 investigators from 9 countries.
Main Methods:
- A two-day international conference.
- Presentations and discussions by leading world authorities in interstitial lung diseases.
Main Results:
- Extensive data on rare lung disorders were discussed.
- Recent advances in the clinical management of these diseases were highlighted.
Conclusions:
- The conference underscored significant progress in understanding and managing rare pulmonary diseases.
- Collaboration among international experts is crucial for advancing respiratory medicine.